Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Farmers Insurance
Express Scripts
Cantor Fitzgerald
Cerilliant
QuintilesIMS
Johnson and Johnson
McKinsey
Baxter
Federal Trade Commission

Generated: January 23, 2018

DrugPatentWatch Database Preview

VELOSULIN BR Drug Profile

« Back to Dashboard

When do Velosulin Br patents expire, and when can generic versions of Velosulin Br launch?

Velosulin Br is a drug marketed by Novo Nordisk Inc and is included in two NDAs.

The generic ingredient in VELOSULIN BR is insulin recombinant purified human. There are thirty-nine drug master file entries for this compound. Additional details are available on the insulin recombinant purified human profile page.
Summary for VELOSULIN BR
Drug patent expirations by year for VELOSULIN BR

US Patents and Regulatory Information for VELOSULIN BR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novo Nordisk Inc VELOSULIN BR insulin recombinant human INJECTABLE;INJECTION 021028-001 Jul 19, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novo Nordisk Inc VELOSULIN BR HUMAN insulin recombinant purified human INJECTABLE;INJECTION 019450-001 May 30, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Farmers Insurance
Fish and Richardson
Chubb
Novartis
McKinsey
Merck
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot